Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets
Zydus Cadila has received final nod from the US health regulator to market generic Lansoprazole delayed release orally disintegrating tablets in the s29-11-2018
Zydus Cadila gets USFDA nod to market generic Lansoprazole tablets
Zydus Cadila has received final nod from the US health regulator to market generic Lansoprazole delayed release orally disintegrating tablets in the sAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives approvals from the USFDA for Lansoprazole Tablets and Linagliptin tabletsZydus Cadila gets USFDA nod for generic muscle spasm treatment tablets
The tablets will be manufactured at the group's formulations manufacturing facility at Baddi.Announcement under Regulation 30 (LODR)-Press Release / Media Release
'Zydus receives final approval from the USFDA for Baclofen Tablets'Zydus Cadila gets USFDA nod for generic cholesterol drug
Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats and raise good cholesterol (HDL) in the blood.Announcement under Regulation 30 (LODR)-Press Release / Media Release
Zydus receives approvals from the USFDA for Atorvastatin Calcium Tablets and Dimethyl Fumarate Delayed-Release CapsulesAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 20, 2018 titled 'Zydus receives tentative approval from the USFDA for Deferasirox Tablets'.Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 16, 2018 titled 'Zydus receives final approval from the USFDA for Abacavir & Lamivudine Tablets and Fondaparinux Sodium Injection'.Zydus Cadila gets USFDA nod for leukemia injection
Zydus Cadila on Wednesday said it has received approval from the US health regulator to market Arsenic Trioxide injection, used to treat a type of leAnnouncement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed a copy of press release dated November 14, 2018 titled 'Zydus receives final approval from the USFDA for Arsenic Trioxide Injection'.